Objectives To assess endothelial function and arterial stiffness in women with a previous pregnancy complicated by pre-eclampsia (PE) 
INTRODUCTION
The role of microcirculation in clinical conditions with profound hemodynamic imbalance, such as cardiovascular (CV) disease and pre-eclampsia (PE), is emerging. Better knowledge of common pathways may provide novel insights into understanding the increased risk of CV disease in women who develop PE and its complications 1 . Known triggers for PE, such as hypoxia, inflammation and angiogenic imbalance, may also trigger the CV impairment that has been documented in non-pregnant women with previous PE 2 . Severe PE leads to maternal hemodynamic instability due to endothelial damage 3 , and many of its symptoms and complications seem to suggest a microcirculatory dysfunction. Hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome, which is considered to be an expression of the severity of PE 4 , occurs in 0.2-0.8% of pregnancies and coexists with PE in 70-80% of cases 5 . Although little is known about HELLP syndrome and the pathophysiology is not completely understood, its pathognomonic alterations likely reflect a disturbance in the microcirculation. These changes occurring during gestation may increase the risk for CV morbidity later in life. While a link between PE and CV performance status has been demonstrated 6, 7 , with evidence of a persistent endothelial deterioration and increased aortic stiffness in women with previous PE [8] [9] [10] , in contrast, there are few data on hemodynamic function in women who have experienced HELLP syndrome 11, 12 . Thus, it remains unclear whether differences exist in the systemic vasculature after pregnancy complicated by PE with and those without HELLP syndrome.
Our aim was to assess endothelial function and arterial stiffness in women with a previous pregnancy complicated by PE who also experienced HELLP syndrome, comparing these findings to those in women with previous PE without HELLP syndrome and to those in healthy controls with previous uncomplicated pregnancy, in order to investigate the influence of HELLP syndrome on subsequent CV impairment.
SUBJECTS AND METHODS
This was a prospective single-center case-control study performed in compliance with the Declaration of Helsinki and approved by the local ethics committee. Results are reported following STROBE guidelines 13 . We searched our electronic database for pregnancies that had been complicated by PE or HELLP syndrome and treated at the Maternal Fetal Medicine Unit of the Department of Obstetrics and Gynecology, University of Brescia, Italy between January 2007 and December 2013. Women were characterized as having HELLP syndrome if they had evidence of all of the following conditions: platelet count < 100 000/mm 3 , abnormal peripheral smear, abnormal liver function test (aspartate aminotransferase level > 70 IU/L; and lactate dehydrogenase level > 600 IU/L and/or bilirubin level > 1.2 mg/dL) 14 . According to the International Society for the Study of Hypertension in Pregnancy, PE was defined as a blood pressure of at least 140/90 mmHg, on two occasions 4-6 h apart, after the 20 th week of gestation, in previously normotensive women, accompanied by proteinuria ≥ 300 mg/24 h 15 . Early-onset PE was defined as PE diagnosed < 34 weeks' gestation, with late-onset PE being ≥ 34 weeks.
Women were excluded if analysis of their medical charts before pregnancy and at the 6-month follow-up revealed evidence of any of the following CV risk factors: smoking habit, dyslipidemia, overweight, diabetes mellitus or chronic hypertension. All obstetric scans were performed at diagnosis of PE by experienced sonographers, using an iU22 (Philips Healthcare, Bothell, WA, USA) ultrasound machine, equipped with a V6-2 curved array volume transducer. Uterine artery (UtA) velocimetry Doppler was performed at the apparent crossover of the uterine and external iliac arteries. Pulsatility indices (PIs) of both UtAs were measured and their mean was calculated. Abnormal UtA-PI was defined according to reference values 16 . Umbilical artery Doppler waveforms were obtained from a free-floating portion of the umbilical cord. Intrauterine growth restriction (IUGR) was defined as fetal abdominal circumference < 10 th percentile according to local standards 17 and abnormal umbilical artery PI > 95 th percentile, irrespective of the presence of absent or reversed end-diastolic flow. The study population was subject to the following additional exclusion criteria: multiple pregnancy, chromosomal abnormality or fetal malformation, maternal cardiac disease or immune disorder, PE superimposed on chronic hypertension and pregestational renal disease.
We selected as controls 60 healthy women with previous uncomplicated pregnancy, who met the inclusion/exclusion criteria and who delivered in our hospital during the same period as the study group.
All women were contacted by telephone between 6 months and 4 years after delivery to assess their eligibility. All eligible women attended a single appointment at the Cardiology Unit, University of Brescia, Italy, to undergo an echocardiographic assessment as well as peripheral arterial tonometry (PAT) and arterial stiffness assessment. The results of this assessment are reported in our previous publication 18 . The study cohort was free from any medication at the time of assessment, including oral contraceptive. All examinations were performed in the same temperature-controlled room, during the morning after a night of fasting. All women gave their written informed consent to participate. Data regarding demographic and clinical characteristics during pregnancy were collected from obstetric charts of all women. The entire study cohort had normal blood pressure values and absence of any pathological proteinuria 6 months after delivery. Blood pressure during pregnancy, 6 months after delivery and at CV evaluation was assessed using a standard, calibrated, electronic sphygmomanometer (OMRON Healthcare, Hoofddorp, The Netherlands). This automatically inflates the cuff to beyond systolic pressure and then deflates gradually, recording blood pressure by means of oscillometric technology. During blood-pressure measurement, the woman was relaxed and sitting at a 45
• angle. An appropriate cuff size was used, and placed at the level of the woman's heart. The mean of three blood pressure measurements was recorded for each arm, and the arm in which the highest sitting diastolic pressure was recorded was the one used for all subsequent readings throughout the study. Every effort was made to have the same staff member obtain blood pressure measurements in each individual patient, at the same time of day, using the same equipment. Mean arterial pressure was calculated as (SBP + (2 × DBP))/3, with SBP and DBP being systolic and diastolic blood pressure, respectively. 
EndoPAT measurements
To assess endothelial function, PAT signals were obtained using the EndoPAT-2000 device (Itamar Medical Ltd., Caesarea, Israel), which has been validated and used previously to assess peripheral arterial tone in other populations [19] [20] [21] [22] [23] . A specially designed finger probe is placed on the middle finger of both the subject's hands. The probe comprises a system of inflatable latex air cuffs connected by pneumatic tubes to an inflating device, which is controlled through a computer algorithm. A constant counter pressure (predetermined by baseline DBP) is applied through the air cushions. This prevents venous pooling, thus avoiding veno-arteriolar reflex vasoconstriction. There is no occlusion of arterial blood flow. Pulsatile volume changes of the distal digit induce pressure alterations in the finger cuff, which are sensed by pressure transducers and transmitted to, and recorded by, the EndoPAT-2000 device. A decrease in arterial blood volume in the distal fingertip causes a decrease in pulsatile arterial column changes, which are reflected in a decrease in the measured PAT signal, and vice versa. Endothelial function is assessed via a reactive hyperemia (RH) protocol. This consists of a 5-min baseline measurement, after which a blood-pressure cuff on the test arm is inflated to 60 mmHg above baseline SBP, or at least 200 mmHg, for 5 min. Occlusion of pulsatile arterial flow is confirmed by the reduction of the PAT tracing to zero. After 5 min, the cuff is deflated, and the PAT tracing is recorded for a further 5 min. The ratio of the PAT signal after cuff release compared with the baseline is calculated through a computer algorithm, automatically normalizing for baseline signal and indexed to the contralateral arm. The calculated ratio is the 'RH-PAT index' or 'reactive hyperemia index' (RHI). Its normal value is > 2.00 (pure number), while definitive endothelial dysfunction is indicated by a value ≤ 1.67. Values > 1.67 ≤ 2.00 are of unclear significance. At the same time, the software also calculates the peripheral augmentation index (AIx), which is a measure of arterial stiffness (see below). Since this parameter is influenced by heart rate, it is automatically standardized for a heart rate of 75 bpm (AIx@75). According to the EndoPAT software, peripheral AIx@75 is normal when < 17%. Typical examples of normal and abnormal EndoPAT traces are shown in Figure 1 .
Pulse-wave analysis
Central BP was measured by arterial tonometry, using a Vascular Explorer (Enverdis GmbH, Jena, Germany) device, which calculates aortic stiffness parameters from the oscillatory recorded pressure waves of the brachial and posterior tibial arteries and from body surface linear measurements (brachial-jugular, jugular-pubis symphysis, jugular-ankle). Using inflatable upper and lower arm cuffs with high fidelity sensors, pulsatile volume changes (resulting from pulsatile fluctuations of the two arteries) are transduced into pressure curves. Pulse waves are recorded when the two arteries are completely occluded at a cuff pressure of 35-40 mmHg above SBP. A dedicated computer program is used to further analyze the recorded pulse waves. The pulse transit time (PTT) is determined from the decomposition of the general aortic pressure wave using the reflection method. This measurement is based on the fact that the forward-traveling pulse wave (generated by the ejection of the left ventricle) is reflected in the periphery, creating a second, reflected wave. PTT is determined from the foot-foot difference in time between the forward-traveling and the beginning of the reflected pressure wave (reflection method under brachial stop/flow conditions), and aortic pulse-wave velocity (PWV) is automatically calculated from PTT and the traveling distance between the jugulum (sternal notch) and the symphysis pubis, according to the manufacturer's recommendations. Brachial-ankle PWV is recorded by means of simultaneous cuff measurements taken from the upper arm and the ankle at DBP. Carotid-femoral PWV (cfPWV) is calculated from brachial-ankle and aortic measurements. According to European reference values and techniques, this value was multiplied by Data are given as mean ± SD or n (%). Endothelial dysfunction indicated by reactive hyperemia index (RHI) ≤ 1.67 (normal value is > 2.00).
Arterial stiffness indicated by peripheral augmentation index corrected for a heart rate of 75 bpm (AIx@75) (abnormal when ≥ 17%), aortic AIx@75 (abnormal at ≥ 35%) or carotid-femoral pulse-wave velocity (cfPWV) (abnormal when cfPWV × 0. 0.8 as a correction factor for body surface distance measurements, and values > 9.6 m/s (0.8 × 12 m/s) were considered pathological 24 . Finally, another central hemodynamics parameter measuring arterial stiffness, the aortic AIx@75, is calculated from brachial pressure curves in combination with automated transfer algorithms. The manufacturer suggests that aortic AIx@75 is abnormal at ≥ 35%.
Statistical analysis
All analyses were performed using the statistical package IBM SPSS Statistics 20 for Windows (IBM Corp., Armonk, NY, USA). Continuous variables were tested visually for normality using quantile-quantile plots and are presented as mean ± SD, while categorical variables are presented as frequency (n) and percentage of the sample. After Levene's test for homoscedasticity, Welch's unequal variances analysis of variance (ANOVA) was performed to analyze the difference between means for continuous variables (independent samples Welch's t-test if two groups), and the Dunnett C test was used for post-hoc analysis. The χ 2 test was used for assessing differences between proportions. Bivariate Pearson's correlations were calculated to assess the association between the degree of biochemical alterations during pregnancy (thrombocytopenia, liver enzyme elevation, hemolysis) and the PAT/arterial stiffness indices. Four multivariate linear regression analyses were run to test the independent ability of HELLP syndrome, gestational age at the diagnosis of PE, IUGR, mean UtA-PI at diagnosis of the disease, birth-weight percentile, maternal age, body mass index and SBP/DBP blood pressure at cardiological evaluation (independent variables), to predict the previously specified vascular parameters, after correcting each variable for the others. For all statistical tests, P < 0.05 was considered significant. All tests were two-tailed.
RESULTS
In total, we found in our electronic database 493 cases of PE and 79 of PE with HELLP syndrome during the period considered, of which 96 and 49, respectively, were eligible for inclusion ( Figure S1 ). A convenience sample of 60 women with previous PE but not HELLP syndrome was selected and the women enrolled. No woman was breastfeeding and none was taking oral contraceptives.
The demographic and clinical characteristics during gestation of the study cohort and controls are summarized in Table S1 . Women with PE who developed HELLP syndrome had lower gestational age at delivery compared with controls (P = 0.001), and lower maternal age at delivery (P = 0.03) and a higher prevalence of early-onset PE (P < 0.001) compared with those with PE but not HELLP, but a reduced incidence of IUGR (P = 0.021) compared with both controls and those with PE but not HELLP. However, considering only early-onset IUGR requiring delivery before 34 weeks' gestation, no difference remained between the two PE groups (37.5% vs 30.4%, respectively; P = 0.736). Both PE groups had a lower gestational age at delivery than did controls (P = 0.001), a higher Cesarean section rate (P = 0.003) and a reduced birth weight (P < 0.001). Table 1 presents the clinical characteristics at cardiology assessment and the PAT and arterial stiffness indices. Maternal age at assessment did not differ among the three Table 2 Multivariate linear regressions between peripheral arterial tonometry and arterial stiffness parameters and: HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome, gestational age at onset of pre-eclampsia, intrauterine growth restriction (IUGR), mean uterine artery pulsatility index (UtA-PI) at diagnosis of the disease, birth-weight percentile, maternal age, body mass index (BMI) and systolic/diastolic blood pressure (SBP/DBP) at current assessment (considered as independent variables), in women with previous pre-eclampsia
RHI
Peripheral AIx@75 Aortic AIx@75 cfPWV × 0.8 Endothelial dysfunction is indicated by reactive hyperemia index (RHI) ≤ 1.67 (normal value is > 2.00). Arterial stiffness is indicated by peripheral augmentation index corrected for a heart rate of 75 bpm (AIx@75) (abnormal when ≥ 17%), aortic AIx@75 (abnormal at ≥ 35%) or carotid-femoral pulse-wave velocity (cfPWV) (abnormal when cfPWV × 0.8 > 9.6 m/s). groups. The time from delivery to cardiology assessment was greater in women with a history of HELLP syndrome than the others (P = 0.006). DBP was higher in the HELLP group than in controls (P = 0.001). With the exception of cfPWV × 0.8 > 9.6 m/s, all of the vascular indices studied were significantly different in women with complicated pregnancies, both those with and those without HELLP, compared with controls. While there was apparently a trend for PAT/arterial stiffness indices to be more abnormal in women with HELLP syndrome, there was no statistical significance, on comparison with women with previous PE without HELLP, in the rate of RHI ≤ 1.67 (28.6% vs 18.3%, P = 0.254), RHI ≤ 2.00 (61.2% vs 41.7%, P = 0.055), peripheral AIx@75 ≥ 17% (38.8% vs 30.0%, P = 0.417), aortic AIx@75 ≥ 35% (29.2% vs 20.0%, P = 0.461) and cfPWV × 0.8 > 9.6 m/s, which occurred in only three women, all in the group without previous HELLP (0% vs 5.0%, P = 0.251).
There were no correlations between the degree of biochemical alteration during pregnancy (degree of platelet consumption, liver enzyme elevation, hemolysis) and PAT/arterial stiffness indices. The results of multivariate regression analyses are reported in Table 2 . Endothelial function alone showed a close and independent relationship with HELLP, IUGR and gestational age at diagnosis of PE.
We divided cases into four subgroups according to the presence/absence of HELLP syndrome and of early-onset IUGR. Endothelial dysfunction showed a significant relationship, being more frequent in women who had experienced both HELLP and early-onset IUGR (P = 0.001) (Figure 2 ). Arterial stiffness was not significantly different between groups.
DISCUSSION
In this study we explored endothelial function and arterial stiffness in women with a history of PE with or without HELLP syndrome. When comparing these women, we observed no significant differences in their vascular performance status, but a trend towards more vascular abnormalities in those who had been affected by HELLP. Indeed, multivariate analysis confirmed the independent predictive role of a history of HELLP syndrome as regards endothelial dysfunction a few years after delivery. Endothelial dysfunction was significantly more prevalent among women who had experienced both HELLP and early-onset IUGR, indicating that these women may represent a subgroup with higher risk for future vascular alterations compared with the others.
The present study is the first to evaluate specifically endothelial function and arterial stiffness in non-pregnant women with a previous pregnancy complicated by HELLP syndrome in comparison with those who developed PE alone and with controls. There are limited data reported in the literature on maternal CV function during or after pregnancy complicated by HELLP syndrome. Fischer et al. 11 found diminished forearm vasodilatation after arterial occlusion in patients with PE but not in those with HELLP, suggesting different pathogenetic mechanisms in the two conditions. In contrast, Cornette et al. 12 demonstrated that, in women with severe PE, the presence of HELLP syndrome is characterized by impaired sublingual microcirculatory perfusion. Our group observed that HELLP syndrome may lead to more severe CV remodeling than does PE alone between 6 months and 4 years after delivery 18 . However, the small number of patients included in the cited studies, together with the differences in the timing and methods of measurement, make data interpretation quite difficult.
The other reports available about differences between HELLP syndrome and PE without HELLP explored specifically placental histological patterns. Smulian et al. 25 documented similar lesions in the placentae of PE women with and those without HELLP syndrome, thus excluding the possibility that the two conditions might have different underlying etiology. Analyzing HELLP from a different point of view, our results partly confirm this hypothesis. Endothelial activation, oxidative stress and proinflammatory status may form the basis of CV sequelae and are in common with PE and HELLP syndrome themselves. However, in accordance with our echocardiographic findings 18 , the data presented here suggest that a history of HELLP syndrome is an independent predictor of future endothelial dysfunction, after correcting for gestational age at diagnosis of PE and the presence of IUGR. In fact, early onset of PE is associated with a subsequent higher risk of CV, as we demonstrated previously 10 . Moreover, independent from PE, IUGR is associated with long-term development of CV disease in the mother, particularly if IUGR is early-onset [26] [27] [28] [29] . As a consequence, we observed that the co-presence of HELLP and early-onset IUGR apparently leaves the mother with an increased risk for subsequent endothelial dysfunction.
Given the importance of CV prevention, large population-based studies are needed to confirm the independent additive role of these factors in order to identify which women might benefit from a cardiology follow-up. Why HELLP syndrome leads to a higher rate of vascular sequelae than does PE alone is not immediately obvious; we can hypothesize that the inflammatory response is greater in the case of HELLP syndrome, probably persisting and/or causing more pronounced myocardial dysfunction 5, 30 . Focused research is needed to confirm this hypothesis.
Our study has several limitations. First, the number of cases included was relatively small. Second, we did not perform a preconceptional assessment of maternal hemodynamic performance status with which to compare the postpartum data, so we cannot exclude that vascular impairment was already present before pregnancy. Third, our study cohort consisted mainly of white European women who were free from CV risk factors, and results may differ in other ethnic groups and/or in patients with comorbidities. Furthermore, we did not assess the repeatability of our measurements. However, the techniques we employed have been shown to have good intra-and interobserver variability [31] [32] [33] . Finally, the incidence of early-onset PE was higher in the HELLP group, while that of IUGR was higher in those with only PE; these issues, together with other confounders (e.g. the lower maternal age at delivery and the longer time from delivery to assessment in the HELLP group) may have led to the differences being insignificant between HELLP and PE groups. However, the multivariate analysis allowed us to correct for these factors and to analyze the independent roles of HELLP, early-onset PE and IUGR in determining vascular alterations.
In conclusion, we found a consistent overlap between HELLP syndrome and PE without HELLP as regards postpartum vascular findings, including endothelial function and aortic stiffness. However, a history of HELLP syndrome, IUGR and early-onset PE seems to classify a subgroup of women with higher risk for future endothelial dysfunction.
